• Sulfisomidine Workflows for Enzyme and Microbial Research

  2026-09-02

  Sulfisomidine, also indexed as sulfamethin, connects antibacterial metabolism studies with quantitative hPON1 inhibition assays. This practical guide covers stock preparation, mixed-type enzyme kinetics, microbial screening, environmental transformation workflows, and troubleshooting for reproducible results.

• LLC-PK1/MDR1 Model for BBB Permeability Prediction

  2026-09-02

  Hu et al. developed a high-throughput surrogate blood-brain barrier model by combining LLC-PK1-MOCK and LLC-PK1-MDR1 Transwell systems with a correction for lysosomal drug trapping. The study links in vitro permeability with unbound brain distribution and provides a practical framework for separating passive diffusion, P-glycoprotein efflux, and intracellular sequestration during early CNS drug screening.

• AO/PI Staining Solution for Diabetic Nephropathy

  2026-09-01

  Translate diabetic nephropathy mechanism studies into cleaner viability measurements with dual fluorescent DNA dyes. AO/PI Staining Solution supports live dead cell discrimination, impurity exclusion, and reproducible fluorescence-based cell counting in podocyte and primary-cell workflows.

• Lithium, Exosomal Wnt10a, and Bone Regeneration

  2026-09-01

  The 2024 ACS Applied Materials & Interfaces study identifies a mechanism by which lithium enhances osteogenesis: MARK2-dependent Rab11a/Rab11FIP1 trafficking increases exosomal Wnt10a secretion, activating β-catenin signaling in bone mesenchymal stem cells. Its comparison of lithium-conditioned exosomes and GelMA hydrogels provides a mechanistic and biomaterials framework for improving bone repair, while also highlighting the need for pathway-specific validation in future studies.

• CTOP: A Causal Tool for μ-Opioid Circuit Research

  2026-08-31

  CTOP is a selective μ-opioid receptor antagonist for separating receptor-level causality from circuit-level observations. This guide connects CTOP pharmacology with recent findings on mechanical opioid hypersensitivity and provides a rigorous framework for binding, signaling, and pain mechanism research.

• CTOP for μ-Opioid Receptor Signaling Studies

  2026-08-31

  CTOP provides a selective pharmacological way to test whether μ-opioid receptor activation drives cellular signaling, mechanical hypersensitivity, or opioid tolerance. This workflow connects receptor-level assays with the brain-to-spinal circuit identified in recent mouse pain research while emphasizing route controls, timing, and interpretation.

• dhcr7 Knockout Grass Carp Shows GCRV Resistance

  2026-08-30

  A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and found substantially improved survival after GCRV-II challenge, together with stronger antiviral responses and reduced tissue damage. The results provide in vivo evidence that cholesterol biosynthesis can influence antiviral defense and identify dhcr7 as a candidate target for disease-resistant aquaculture breeding.

• Ampicillin Sodium: Mechanism and Research Benchmarks

  2026-08-29

  Ampicillin sodium is a β-lactam antibiotic used to study bacterial cell wall biosynthesis inhibition. Vendor-reported benchmarks include a transpeptidase IC50 of 1.8 μg/mL and an MIC of 3.1 μg/mL, but assay conditions should be confirmed before comparison across experiments.

• DiscoveryProbe Stem Cell Compound Library Plus

  2026-08-28

  DiscoveryProbe Stem Cell Compound Library Plus supports mechanism-guided stem cell pathway profiling and high-content phenotypic screening. This article shows how quantitative cell-state readouts, pathway coverage, and orthogonal validation can convert a broad compound screen into defensible assay decisions.

• Foretinib, ICD, and Anti-CD47 Therapy in Colorectal Cancer

  2026-08-28

  The reference study identifies foretinib as an inducer of immunogenic cell death in colorectal cancer, linking c-Met/VEGFR2 inhibition to p53–DR5 signaling, DAMP release, and immune activation. Its combination with anti-CD47 immunotherapy suggests a complementary strategy that couples tumor-cell killing with improved antitumor immune recognition.

• HRP Goat Anti-Mouse IgG (H+L) Antibody

  2026-08-27

  HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) provides an enzyme-labeled secondary reagent for detecting mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be used as a default secondary for non-mouse or non-IgG primaries, fluorescent workflows, or assays that are incompatible with HRP substrates.

• SU6656: Src Tyrosine Kinases Inhibitor Workflows

  2026-08-27

  SU6656 connects megakaryocyte polyploidization studies with endothelial radiosensitization workflows. This practical guide explains how to screen the compound in hiPSC-derived platelet production, compare it with alternative maturation modulators, and design controls for cancer research.

• Luminescent ATP Detection Assay Kit for Colitis

  2026-08-26

  Use the Luminescent ATP Detection Assay Kit to add a quantitative bioenergetic layer to NOX2/ROS/mitochondrial studies of ulcerative colitis. Its acid-free lysis workflow supports cellular ATP quantification and ATP measurement in tissue samples while preserving material for protein-based follow-up.

• Z-YVAD-FMK: Caspase-1 Inhibitor Workflows

  2026-08-26

  Z-YVAD-FMK provides a cell-permeable, irreversible way to test whether caspase-1 drives inflammatory signaling, pyroptosis, or secondary cell death. This guide turns the compound’s selectivity and solubility profile into practical cell-based, cancer research, and species-aware assay workflows.

• Palonosetron hydrochloride Workflow Guide

  2026-08-25

  Build reproducible 5-HT3 receptor assays and connect nanomolar receptor pharmacology with OCT2 and MATE1 transporter studies. This workflow guide highlights concentration selection, translational model design, and practical troubleshooting for cancer research.

554 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page